Abstract:The aim of this work was to study the regulation of the calcineurin antagonist regulator of calcineurin 1 (RCAN1) in rat skeletal muscles after exhaustive physical exercise, which is a physiological modulator of oxidative stress. Three skeletal muscles, namely extensor digitorum longus (EDL), gastrocnemius, and soleus, were investigated. Exhaustive exercise increased RCAN1-4 protein levels in EDL and gastrocnemius, but not in soleus. Protein oxidation as an index of oxidative stress was increased in EDL and ga… Show more
“…We found that rat MCs have higher basal protein level of RCAN1.1 compared with RCAN1.4. HG induced the up-regulation of RCAN1.4 protein rather than RCAN1.1 protein, which is consistent with previous studies showed that RCAN1.1 is constitutively expressed in most issues, while RCAN1.4 transcription is induced de novo by several stimuli [32][33][34][35]. In addition, the mRNA level of RCAN1.4 rose in the early stage of HG stimulation and fell 12 h later, while the protein level of RCAN1.4 remained high at 36 h. The discrepancy between RCAN1.4 mRNA and protein levels suggested that there may be translational or post-translational regulation.…”
High glucose (HG)-induced mitochondrial dynamic changes and oxidative damage are closely related to the development and progression of diabetic kidney disease (DKD). Recent studies suggest that regulators of calcineurin 1 (RCAN1) is involved in the regulation of mitochondrial function in different cell types, so we investigate the role of RCAN1 in mitochondrial dynamics under HG ambience in rat glomerular mesangial cells (MCs). MCs subjected to HG exhibited an isoform-specific up-regulation of RCAN1.4 at both mRNA and protein levels. RCAN1.4 overexpression induced translocation of Dynamin related protein 1 (Drp1) to mitochondria, mitochondrial fragmentation and depolarization, accompanied by increased matrix production under normal glucose and HG ambience. In contrast, decreasing the expression of RCAN1.4 by siRNA inhibited HG-induced mitochondrial fragmentation and matrix protein up-regulation. Moreover, both mitochondrial fission inhibitor Mdivi-1 and Drp1 shRNA prevented RCAN1.4-induced fibronectin up-regulation, suggesting that RCAN1.4-induced matrix production is dependent on its modulation of mitochondrial fission. Although HG-induced RCAN1.4 up-regulation was achieved by activating calcineurin, RCAN1.4-mediated mitochondrial fragmentation and matrix production is independent of calcineurin activity. These results provide the first evidence for the HG-induced RCAN1.4 up-regulation involving increased mitochondrial fragmentation, leading to matrix protein up-regulation.
“…We found that rat MCs have higher basal protein level of RCAN1.1 compared with RCAN1.4. HG induced the up-regulation of RCAN1.4 protein rather than RCAN1.1 protein, which is consistent with previous studies showed that RCAN1.1 is constitutively expressed in most issues, while RCAN1.4 transcription is induced de novo by several stimuli [32][33][34][35]. In addition, the mRNA level of RCAN1.4 rose in the early stage of HG stimulation and fell 12 h later, while the protein level of RCAN1.4 remained high at 36 h. The discrepancy between RCAN1.4 mRNA and protein levels suggested that there may be translational or post-translational regulation.…”
High glucose (HG)-induced mitochondrial dynamic changes and oxidative damage are closely related to the development and progression of diabetic kidney disease (DKD). Recent studies suggest that regulators of calcineurin 1 (RCAN1) is involved in the regulation of mitochondrial function in different cell types, so we investigate the role of RCAN1 in mitochondrial dynamics under HG ambience in rat glomerular mesangial cells (MCs). MCs subjected to HG exhibited an isoform-specific up-regulation of RCAN1.4 at both mRNA and protein levels. RCAN1.4 overexpression induced translocation of Dynamin related protein 1 (Drp1) to mitochondria, mitochondrial fragmentation and depolarization, accompanied by increased matrix production under normal glucose and HG ambience. In contrast, decreasing the expression of RCAN1.4 by siRNA inhibited HG-induced mitochondrial fragmentation and matrix protein up-regulation. Moreover, both mitochondrial fission inhibitor Mdivi-1 and Drp1 shRNA prevented RCAN1.4-induced fibronectin up-regulation, suggesting that RCAN1.4-induced matrix production is dependent on its modulation of mitochondrial fission. Although HG-induced RCAN1.4 up-regulation was achieved by activating calcineurin, RCAN1.4-mediated mitochondrial fragmentation and matrix production is independent of calcineurin activity. These results provide the first evidence for the HG-induced RCAN1.4 up-regulation involving increased mitochondrial fragmentation, leading to matrix protein up-regulation.
“…RCAN1 is also overexpressed in the brains of individuals with Down syndrome, a disorder with an increased prevalence of AD . Neuronal expression of RCAN1 also increases with aging, and in response to traumatic stressors such as spinal cord injury and exhaustive exercise in muscle . The nutrient stress hyperglycaemia also induces RCAN1 expression in myotubes and pancreatic β‐cells .…”
Section: Rcan1 Expressionmentioning
confidence: 99%
“…19 Neuronal expression of RCAN1 also increases with aging, 20 and in response to traumatic stressors such as spinal cord injury 21 and exhaustive exercise in muscle. 22 The nutrient stress hyperglycaemia also induces RCAN1 expression in myotubes and pancreatic β-cells. 23,24 Such chronic increases in RCAN1 protein levels induce mitochondrial autophagy and a metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells.…”
Section: The Acute Induction Of Rcan1 By Stress-associated Factors Suchmentioning
The regulator of calcineurin 1 (RCAN1) was first discovered as a gene located on human chromosome 21, expressed in neurons and overexpressed in the brains of Down syndrome individuals. Increased expression of RCAN1 has been linked with not only Down syndrome-associated pathology but also an associated neurological disorder, Alzheimer's Disease, in which neuronal RCAN1 expression is also increased. RCAN1 has additionally been demonstrated to affect other cell types including endocrine cells, with links to the pathogenesis of β-cell dysfunction in type 2 diabetes. The primary functions of RCAN1 relate to the inhibition of the phosphatase calcineurin, and to the regulation of mitochondrial function. Various forms of cellular stress such as reactive oxygen species and hyperglycaemia cause transient increases in RCAN1 expression. The short term (hours to days) induction of RCAN1 expression is generally thought to have a protective effect by regulating the expression of pro-survival genes in multiple cell types, many of which are mediated via the calcineurin/NFAT transcriptional pathway. However, strong evidence also supports the notion that chronic (weeks-years) overexpression of RCAN1 has a detrimental effect on cells and that this may drive pathophysiological changes in neurons and endocrine cells linked to Down syndrome, Alzheimer's Disease and type 2 diabetes. Here we review the evidence related to these roles of RCAN1 in neurons and endocrine cells and their relationship to these human health disorders.
“…Oxidative muscle fibres mainly rely on sustained tonic contraction, and the intracellular Ca 2+ concentration is generally maintained at a relatively high level while glycolytic muscle fibres mainly undergo impulsive contraction with a Ca 2+ influx of transient and high intensity, which results in a higher concentration of Ca 2+ in slow muscle fibres than in fast muscle fibres (Zierath & Hawley, ). Recent studies have shown that the expressions of MyHC I and MyHC IIa are regulated by the Ca 2+ /calcineurin/NFAT pathway (Emrani et al, ; Ravel‐Chapuis, Bélanger, Côté, Michel, & Jasmin, ) pacifically, and increase of the intracellular Ca 2+ leads to calcineurin activation and NFAT dephosphorylation consequently. The dephosphorylated NFAT will translocate to the promoter of the gene involved in oxidative metabolism in the nucleus to promote the transformation of glycolytic muscle fibres to oxidative muscle fibres in skeletal muscle (Ehlers, Celona, & Black, ; Lomonosova, Turtikova, & Shenkman, ; Pfluger et al, ).…”
Section: Discussionmentioning
confidence: 99%
“…). Recent studies have shown that the expressions of MyHC I and MyHC IIa are regulated by the Ca 2+ /calcineurin/NFAT pathway(Emrani et al, 2015;Ravel-Chapuis, Bélanger, Côté, Michel, & Jasmin, 2017) pacifically, and increase of the intracellular Ca 2+ leads to calcineurin activation and NFAT dephosphorylation consequently. The dephosphorylated NFAT will…”
As one of the key points related to meat quality, skeletal muscle fibre type is determined by energy metabolism and genetic factors, but its transformation could be also greatly influenced by many factors. Thymol, the primary effective ingredients of thyme, is well known for its anti‐oxidation and anti‐inflammatory, while little is known about its effect on skeletal muscle oxidative metabolism and fibre type switch. Therefore, in order to investigate its effects and possibility to be applied in livestock production, 36 150‐day‐old fattening Pigs were fed with different diet for six‐week experiment. As a result, the drip loss ratio of longissimus dorsi (LD) was significantly reduced (p < .05). Oxidative metabolism‐related enzyme activity, the mRNA levels and protein expression of COX5B and PGC1α, mRNA level of myosin heavy chain I (MyHC I) and protein level of MyHC IIa were significantly upregulated (p < .05). While compared with control group, the protein expression of MyHC IIb was significantly decreased (p < .05). The result revealed that thymol could promote the oxidative metabolism in the muscle of pigs and improve the meat quality to a certain extent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.